File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)

Article: ASO Visual Abstract: Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma

TitleASO Visual Abstract: Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Authors
Issue Date23-Nov-2022
PublisherSpringer
Citation
Annals of Surgical Oncology, 2023, v. 30, n. 2, p. 873 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/337905
ISSN
2021 Impact Factor: 4.339
2020 SCImago Journal Rankings: 1.764

 

DC FieldValueLanguage
dc.contributor.authorChan, WL-
dc.contributor.authorChoi, CW-
dc.contributor.authorWong, IYH-
dc.contributor.authorTsang, THT-
dc.contributor.authorLam, ATC-
dc.contributor.authorTse, RPY-
dc.contributor.authorChan, KK-
dc.contributor.authorWong, CD-
dc.contributor.authorLaw, BTT-
dc.contributor.authorCheung, EE-
dc.contributor.authorChan, SY-
dc.contributor.authorLam, KO-
dc.contributor.authorKwong, D-
dc.contributor.authorLaw, S-
dc.date.accessioned2024-03-11T10:24:49Z-
dc.date.available2024-03-11T10:24:49Z-
dc.date.issued2022-11-23-
dc.identifier.citationAnnals of Surgical Oncology, 2023, v. 30, n. 2, p. 873-
dc.identifier.issn1068-9265-
dc.identifier.urihttp://hdl.handle.net/10722/337905-
dc.languageeng-
dc.publisherSpringer-
dc.relation.ispartofAnnals of Surgical Oncology-
dc.titleASO Visual Abstract: Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma-
dc.typeArticle-
dc.identifier.doi10.1245/s10434-022-12810-8-
dc.identifier.scopuseid_2-s2.0-85145492186-
dc.identifier.volume30-
dc.identifier.issue2-
dc.identifier.spage873-
dc.identifier.eissn1534-4681-
dc.identifier.issnl1068-9265-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats